 |
 |
"About ND0612 straight-line and clinically-significant levodopa blood levels. It also delivers subcutaneous carbidopa to improve the bioavailability of levodopa. ND0612 is being developed for administration via a subcutaneous delivery patch as a new treatment and intervention option in Parkinson's disease treatment. It should significantly improve the management of motor fluctuations even in patients under the best current standard of care with oral levodopa therapy. ND0612 is based on a proprietary sub-cutaneous levodopa/carbidopa drug formulation that bypasses the digestive tract. It continuously delivers levodopa to achieve " I'm not convinced that we want a continuous dose. Seems to me that in a normally working body produces enough dopamine to handle whatever situation we are in. Zoning out in my hammock requires less dopamine than escaping a hungry tiger. Sleeping requires less than watching football. If the researchers really want to reach Nirvana they should work on a delivery system that delivers exactly what we need at exactly when and where we need it. Steve On Apr 16, 2013, at 5:11 AM, Nic Marais wrote: > This looks very promising ;-)) > > Nic 61/19 > > > On 16 April 2013 04:56, Rayilyn Brown <[log in to unmask]> wrote: > >> http://online.wsj.com/article/PR-CO-20130415-905839.html?mod=googlenews_wsj >> >> >> Ray >> Rayilyn >> Brown >> Past Director AZNPF >> Arizona Chapter National Parkinson Foundation >> >> ---------------------------------------------------------------------- >> To sign-off Parkinsn send a message to: mailto: >> [log in to unmask] >> In the body of the message put: signoff parkinsn >> > > ---------------------------------------------------------------------- > To sign-off Parkinsn send a message to: mailto:[log in to unmask] > In the body of the message put: signoff parkinsn Steve from Brattleboro ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn